- HIV-HCV co-infection facing HCV protease inhibitor licensing: implications for cliniciansPatrick Ingiliz
Medical Center for Infectious Diseases, Berlin, Germany
Liver Int 32:1194-9. 2012..However, the decision who to treat or not has to be taken carefully on the basis of fibrosis stage and previous treatment outcomes. In addition, HIV therapy needs to be optimized according to the available drug-drug interaction data...